Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Investing Activities (2020 - 2022)

Bio Essence has reported Cash from Investing Activities over the past 3 years, most recently at -$5527.0 for Q4 2022.

  • Quarterly results put Cash from Investing Activities at -$5527.0 for Q4 2022, up 93.85% from a year ago — trailing twelve months through Dec 2023 was -$147427.0 (up 5.77% YoY), and the annual figure for FY2024 was -$114.0, up 96.85%.
  • Cash from Investing Activities for Q4 2022 was -$5527.0 at Bio Essence, up from -$52053.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BIOE hit a ceiling of -$5527.0 in Q4 2022 and a floor of -$89847.0 in Q4 2021.
  • Median Cash from Investing Activities over the past 3 years was -$9020.0 (2021), compared with a mean of -$25732.0.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 1463.1% in 2021 and later soared 93.85% in 2022.
  • Bio Essence's Cash from Investing Activities stood at -$5748.0 in 2020, then tumbled by 1463.1% to -$89847.0 in 2021, then soared by 93.85% to -$5527.0 in 2022.
  • The last three reported values for Cash from Investing Activities were -$5527.0 (Q4 2022), -$52053.0 (Q3 2022), and -$89847.0 (Q4 2021) per Business Quant data.